Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...

The two-dose measles mumps and rubella (MMR) vaccine is widely available, with the first dose recommended for children between the ages of 12 and 15 months and the second dose recommended between ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition ...

HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told ...

Robert F. Kennedy Jr.’s sister, Kerry, contested her brother’s skepticism on vaccines and begged viewers to go “get every vaccine that’s out there” in an interview with CNN. Speaking on ...

Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah study has been comparing Novavax’s non-mRNA COVID-19 vaccine, adjuvanted ...

A pharmacy in New York City advertises the coronavirus vaccine on March 11. (Spencer Platt/Getty Images) The Centers for Disease Control and Prevention might soon limit its guidance for who should ...

Next year’s COVID vaccine recommendations from the U.S. Centers for Disease Control and Prevention appear likely to be less expansive than in previous years. Notes from a recent meeting of the ...

The Covid vaccines made by Pfizer and Moderna helped lift the world out of the pandemic, but a small group of people were left with debilitating side effects that they attribute to the vaccine.

Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...